A. Karlsson, “The effect of tinzaparin on biomarkers in FIGO stages III-IV ovarian cancer patients undergoing neoadjuvant chemotherapy – the TABANETOC trial: study protocol for a randomized clinical multicenter trial”, AO, vol. 63, no. 1, pp. 581–585, Jul. 2024.